FrankfurtRhineMain ranks amongst Germany’s leading locations for medical, pharmaceutical and industrial biotechnology as well as pharmaceutical research and development.
With the highest density of industrial parks in the entire country, the aforementioned industry sector represents the largest business field in the metropolitan region of FrankfurtRhineMain. Aside from the so-called House of Pharma, the FiZ Frankfurter Innovationszentrum Biotechnologie also offers smaller companies of the life sciences sector laboratory and office space with the aim of promoting innovation and growth.
Thousands of employees research, develop and distribute products of the pharmaceutical and industrial biotechnology sector from right here in Frankfurt, while the three most important German chemical associations – DECHEMA, GDCh and VCI – also call the Main metropolis their home. The latter of these three represents the economic interests of some 1,650 companies of the German chemical industry.
Accommodating more than 90 businesses and some 22,000 employees, Höchst Industrial Park is a highly innovative chemical and pharmaceutical business location. The first factory was established here way back in 1868, producing tar dyes. The little ink and dye producer soon found itself growing at a rapid pace. Twenty years after its foundation, the tar dye factory was transformed into a chemical company, introducing its first synthetic medical substance to the market in 1883. In the following years, the establishment of a number of well-known businesses helped the industrial park become even more successful. It was around that time that the world-renowned physician and microbiologist, Robert Koch, handed over his laboratory to the company and thus helped to kick-start the mass production of vaccines and insulin, amongst others. Today, Sanofi produces up to one million insulin pens a day, which go to help diabetes patients in 80 countries around the world.